Format
Sort by

Send to

Choose Destination

Search results

Items: 4

1.

Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial.

Davies C, Pan H, Godwin J, Gray R, Arriagada R, Raina V, Abraham M, Medeiros Alencar VH, Badran A, Bonfill X, Bradbury J, Clarke M, Collins R, Davis SR, Delmestri A, Forbes JF, Haddad P, Hou MF, Inbar M, Khaled H, Kielanowska J, Kwan WH, Mathew BS, Mittra I, Müller B, Nicolucci A, Peralta O, Pernas F, Petruzelka L, Pienkowski T, Radhika R, Rajan B, Rubach MT, Tort S, Urrútia G, Valentini M, Wang Y, Peto R; Adjuvant Tamoxifen: Longer Against Shorter (ATLAS) Collaborative Group.

Lancet. 2013 Mar 9;381(9869):805-16. Erratum in: Lancet. 2013 Mar 9;381(9869):804.

2.

Radiation myelopathy.

Sanyal B, Pant GC, Subrahmaniyam K, Agrawal MS, Mohanty S.

J Neurol Neurosurg Psychiatry. 1979 May;42(5):413-8.

3.

Combined treatment modalities for intracranial tumours.

Sanyal B, Pant GC, Subrahmaniyam K, Sahni K, Agarwal MS, Mohanty S, Rao CJ, Shukla PK.

Indian J Cancer. 1978 Sep;15(3):55-8. No abstract available.

PMID:
757406
4.

Pregnancy complicated by cancer of the cervix--a study of 90 cases.

Subrahmaniyam K, Pant GC, Sanyal B.

Indian J Cancer. 1977 Dec;14(4):340-4. No abstract available.

PMID:
612557

Supplemental Content

Loading ...
Support Center